The Senate Health, Education, Labor and Pensions Committee today 17-3 to pass as amended the Pandemic and All-Hazards Preparedness and Response Act (S. 2333), which would reauthorize the Hospital Preparedness Program at the current funding level of $385 million through fiscal year 2029. Among other provisions, the bill would require drug makers to notify the Food and Drug Administration when they anticipate a meaningful shortage and report who makes the active pharmaceutical ingredients in their drugs. AHA has urged Congress to at least double current annual funding for the HPP, which it called “vastly insufficient,” as well as address drug and device shortages.

Related News Articles

Headline
In a statement submitted to the Senate Finance Committee Dec. 5 for a hearing on drug shortages and potential health policy solutions, AHA reiterated its…
Headline
More than 100 organizations, including the AHA, urged congressional leaders Nov. 14 to reauthorize for an additional five years the Pandemic and All-Hazards…
Headline
The AHA, AHIP, Alliance of Community Health Plans, American Medical Association and Kaiser Permanente have formed a coalition that will recommend strategies to…
Headline
The Drug Enforcement Administration and Substance Abuse and Mental Health Services Administration Oct. 6 released a temporary rule extending telehealth…
Headline
The Federal Emergency Management Agency resumed processing disaster relief funding for over 2,400 projects, including vital funding for hospitals, thanks to $…
Headline
Karie Gibson, a licensed clinical psychologist who leads one of the FBI’s five behavioral analysis units, shares a behavioral threat assessment approach to…